Asia-Pacific cardiovascular devices market is projected to grow at a significant CAGR of 6.6% during the forecast period. The continuous rise in geriatric population is offering growth to Asia-Pacific cardiovascular devices market. China is the second largest economy after the US and China has the world’s largest population (1.4 billion), followed by India (1.3 billion). Both China and India hold 40% of total world population share. As population of India and China grows, its expanding share of older adults is particularly notable. The United Nations Population Division projects that India’s population aged 50 and older will reach 34% by 2050.
A full report of Asia-Pacific Cardiovascular Devices Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-cardiovascular-devices-market
Between 2010 and 2050, the share 65 and older age group is expected to increase from 5% to 14%, while the share in the oldest age group (80 and older) will triple from 1% to 3%. Furthermore, Chinese government is projecting that the country’s aged population (above 60 years old) will reach 255 million by 2020. The country’s aging population will grow at an average rate of 6.4 million every year. By 2020, there will be 255 million elders, representing at least 17.8% of the entire Chinese population. With 1.4 billion and 1.3 billion people in China and India respectively, the aging, health and chronic conditions are also increasing. The rising geriatric population and associated prevalence of chronic disease in them continue to spur the demand for catheterization in healthcare centers, hospitals and surgical units.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-cardiovascular-devices-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Type
- Countries Covered- China, India, Japan, and Rest of Asia-Pacific
- Key Companies Profiled- Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic PLC, Terumo Corp., and Becton, Dickinson and Co.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in base year?
- Which segment/region will project fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Asia-Pacific Cardiovascular Devices Market – Segmentation
By Type
- Diagnostic and Monitoring Devices
o MRI
o Electrocardiogram (ECG)
o Remote Cardiac Monitoring
o Cardiac CT
o Others (PET scan)
- Surgical Devices
o Stents
o Catheters
o Cardiac Assist Devices
o Cardiac Rhythm Management Device
o Others (Heart Valves and Grafts)
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.
